Unicycive Therapeutics (UNCY) Stock Chart & Stock Price History → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free UNCY Stock Alerts $1.13 -0.03 (-2.59%) (As of 05/8/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Unicycive Therapeutics Stock Price Performance5 Day Performance+0.89%1 Month Performance-14.39%3 Month Performance+1.80%6 Month Performance+97.59%Year-To-Date Performance+30.23%1 Year Performance-25.66% Receive UNCY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Unicycive Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Gold Safe ExchangeGold Set to EXPLODE!Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! UNCY Stock Chart for Thursday, May, 9, 2024 UNCY Chart by TradingView Unicycive Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/08/2024$1.16$1.13-2.59%$1.15$1.1170,275 shs$42.50 million05/07/2024$1.18$1.16-1.69%$1.20$1.14149,758 shs$43.63 million05/06/2024$1.12$1.18+5.36%$1.21$1.10363,816 shs$44.38 million05/03/2024$1.12$1.12$1.15$1.11168,641 shs$42.12 million05/02/2024$1.14$1.12-1.32%$1.17$1.10238,990 shs$42.12 million05/01/2024$1.12$1.14+1.34%$1.16$1.11273,982 shs$42.12 million Get the Latest News and Ratings for UNCY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Unicycive Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/30/2024$1.22$1.12-8.20%$1.25$1.09523,099 shs$38.93 million04/29/2024$1.03$1.22+18.45%$1.29$1.011.99 million shs$42.41 million04/26/2024$0.97$1.03+6.19%$1.03$0.95232,305 shs$35.80 million04/25/2024$1.04$0.97-6.73%$1.05$0.93498,047 shs$33.72 million04/24/2024$1.07$1.04-2.80%$1.09$1.04179,329 shs$36.15 million04/23/2024$1.15$1.07-6.96%$1.19$1.07243,117 shs$37.19 million04/22/2024$1.07$1.15+7.48%$1.20$1.05458,697 shs$39.97 million04/19/2024$1.09$1.07-1.83%$1.13$1.04226,754 shs$37.19 million04/18/2024$1.16$1.09-5.63%$1.18$1.05893,190 shs$37.89 million04/17/2024$1.13$1.16+2.67%$1.16$1.12137,251 shs$40.15 million04/16/2024$1.14$1.13-1.32%$1.14$1.02535,343 shs$39.11 million04/15/2024$1.22$1.14-6.56%$1.24$1.101.07 million shs$39.63 million04/12/2024$1.25$1.22-2.40%$1.28$1.17410,594 shs$42.41 million04/11/2024$1.30$1.25-3.85%$1.35$1.25121,640 shs$43.45 million04/10/2024$1.32$1.30-1.52%$1.32$1.26168,586 shs$45.19 million04/09/2024$1.39$1.32-4.69%$1.39$1.29236,069 shs$45.88 million04/08/2024$1.42$1.39-2.46%$1.45$1.36204,243 shs$48.14 million04/05/2024$1.46$1.42-2.74%$1.49$1.37233,816 shs$49.36 million04/04/2024$1.37$1.46+6.57%$1.60$1.421.06 million shs$50.74 million04/03/2024$1.38$1.37-0.72%$1.40$1.33111,536 shs$47.62 million04/02/2024$1.41$1.38-2.13%$1.43$1.37980,019 shs$47.96 million04/01/2024$1.38$1.41+2.17%$1.52$1.36162,167 shs$49.00 million03/29/2024$1.38$1.38$1.48$1.38171,779 shs$47.96 million03/28/2024$1.46$1.38-5.48%$1.48$1.38171,379 shs$47.96 million03/27/2024$1.45$1.46+0.69%$1.47$1.4379,435 shs$50.74 million03/26/2024$1.52$1.45-4.61%$1.56$1.42221,173 shs$50.39 million03/25/2024$1.47$1.52+3.40%$1.60$1.45334,604 shs$52.82 million03/22/2024$1.33$1.47+10.53%$1.48$1.32359,330 shs$51.08 million03/21/2024$1.42$1.33-6.34%$1.43$1.32161,222 shs$46.22 million03/20/2024$1.39$1.42+2.16%$1.45$1.39293,298 shs$49.35 million03/19/2024$1.43$1.39-2.80%$1.47$1.39266,297 shs$48.31 million03/18/2024$1.46$1.43-2.05%$1.51$1.42201,723 shs$49.69 million03/15/2024$1.44$1.46+1.39%$1.52$1.41364,342 shs$50.74 million03/14/2024$1.39$1.44+3.60%$1.73$1.441.71 million shs$50.05 millionThis 1 Biotech Stock has been shocking the markets (Ad)Save the Date: BioStem's 2024 Q1 Call Coming Up!Sign Up for the Live Broadcast here03/13/2024$1.43$1.39-2.80%$1.47$1.38152,843 shs$48.30 million03/12/2024$1.49$1.43-4.03%$1.51$1.33273,049 shs$49.69 million03/11/2024$1.52$1.49-1.97%$1.55$1.47117,116 shs$51.78 million03/08/2024$1.50$1.52+1.33%$1.55$1.39392,538 shs$52.82 million03/07/2024$1.53$1.50-1.96%$1.56$1.48721,864 shs$52.13 million03/06/2024$1.47$1.53+4.08%$1.56$1.44196,341 shs$53.17 million03/05/2024$1.49$1.47-1.34%$1.55$1.40140,485 shs$51.09 million03/04/2024$1.60$1.49-6.88%$1.66$1.47390,538 shs$51.78 million03/01/2024$1.38$1.60+15.94%$1.63$1.39519,390 shs$55.60 million02/29/2024$1.41$1.38-2.13%$1.41$1.38232,250 shs$47.96 million02/28/2024$1.50$1.41-6.00%$1.51$1.25684,483 shs$49.00 million02/27/2024$1.58$1.50-5.06%$1.60$1.48223,424 shs$52.13 million02/26/2024$1.79$1.58-11.73%$1.80$1.211.24 million shs$54.91 million02/23/2024$1.75$1.79+2.29%$1.80$1.61348,608 shs$62.20 million02/22/2024$1.64$1.75+6.71%$1.82$1.51759,216 shs$60.81 million02/21/2024$1.46$1.64+12.33%$1.65$1.38509,052 shs$56.99 million02/20/2024$1.37$1.46+6.57%$1.52$1.30641,701 shs$50.74 million02/19/2024$1.37$1.37$1.44$1.26419,000 shs$47.61 million02/16/2024$1.31$1.37+4.58%$1.44$1.26412,840 shs$47.61 million02/15/2024$1.16$1.31+12.93%$1.33$1.17455,316 shs$45.53 million02/14/2024$1.05$1.16+10.48%$1.17$1.08350,940 shs$40.31 million02/13/2024$1.05$1.05$1.09$1.00145,238 shs$36.49 million02/12/2024$1.11$1.05-5.41%$1.10$0.99229,727 shs$36.49 million02/09/2024$1.14$1.11-2.63%$1.18$1.10169,142 shs$38.57 million02/08/2024$1.15$1.14-0.87%$1.20$1.10283,116 shs$39.62 million Related Companies: Cara Therapeutics Stock Price Chart NextCure Stock Price Chart Lexaria Bioscience Stock Price Chart Sensei Biotherapeutics Stock Price Chart Nabriva Therapeutics Stock Price Chart Eyenovia Stock Price Chart Bolt Biotherapeutics Stock Price Chart Immuneering Stock Price Chart VYNE Therapeutics Stock Price Chart Xilio Therapeutics Stock Price Chart Receive UNCY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Unicycive Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:UNCY) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThis 1 Biotech Stock has been shocking the marketsHuge AlertsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent Nvidia WarningAltimetry348 million Americans lives to END as we know it?The Oxford ClubThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Unicycive Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.